Lifeline BioTechnologies Signs Letter of Intent to Acquire GlobalOdds Holdings, a Premium Technology Provider in Online Gaming

In Aventura, FL, on May 17, 2025, Lifeline BioTechnologies, Inc., a publicly traded company (OTC: LLBO), has declared it has signed a Letter of Intent (LOI) to purchase GlobalOdds Holdings Pty. Limited, a prominent B2B online wagering technology company located in Australia.
GlobalOdds is a software developer that has created a betting platform under an Anjouan Gaming License, offering advanced gaming solutions for the global market. The company has developed its own technology and infrastructure covering various gaming sectors, such as sports betting technologies, casino game integration systems, customer relationship management tools, horse racing platforms, AI-driven personalization engines, and secure payment processing frameworks. This integrated system provides seamless gaming experiences through partnerships and white-label solutions, allowing operators in Europe and Asia to launch sophisticated gaming platforms under their own brands. The company’s technological advancement aims to boost player engagement, enhance retention metrics, and increase operator revenue through data-driven personalization and robust back-office systems.
This acquisition marks LLBO’s initial venture into software development for the global gaming industry and aligns with its shift towards becoming a diversified online software development platform.
Greg Klok, CEO of LLBO, stated, “The LOI with GlobalOdds is a significant step in our strategic plan. GlobalOdds has developed an outstanding technology stack and has gained strong market traction in key regions. This acquisition positions LLBO to benefit from the growth in the global online wagering sector, projected by Horizon Research to exceed $153 billion by 2030.”
Key points of the deal include GlobalOdds supporting various enterprise-level gaming operations through its top-notch platform technology, serving a wide range of B2B clients via SaaS and revenue-sharing partnerships.
The acquisition encompasses proprietary technology, an established customer base, and plans for strategic expansion into Australia and beyond.
The LOI outlines the structure for the proposed acquisition, which is subject to standard due diligence, negotiation of final agreements, regulatory approvals, and other closing conditions.
Upon the successful completion of this deal, LLBO intends to divest its current biotechnology business.
Lifeline BioTechnologies, Inc. (LLBO) is a publicly traded company focusing on strategic acquisitions in high-growth digital sectors, aiming to drive innovation and enhance shareholder value across gaming, fintech, and entertainment.
GlobalOdds Holdings Limited is a leading provider of AI-driven gaming solutions operating in regulated international markets, offering a fully integrated gaming ecosystem tailored to the evolving needs of modern gaming operators and players.
Please note that the above press release contains forward-looking statements based on current expectations and assumptions. Actual results may vary, and the company assumes no obligation to update these statements, except as required by law. It is advised to consider potential risks and uncertainties when evaluating these forward-looking statements as they do not guarantee future performance.